mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |